Shuttle Pharmaceuticals Valuation
| SHPH Stock | USD 0.87 0.01 1.14% |
Today, the company appears to be overvalued. Shuttle Pharmaceuticals has a current Real Value of $0.84 per share. The regular price of the company is $0.87. Our model measures the value of Shuttle Pharmaceuticals from inspecting the company fundamentals such as Shares Outstanding of 3.66 M, return on equity of -1.86, and Shares Owned By Institutions of 1.81 % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Shuttle Pharmaceuticals' valuation include:
Price Book 4.1571 | Enterprise Value 3.6 M | Enterprise Value Ebitda (0.67) |
Overvalued
Today
Please note that Shuttle Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of Shuttle Pharmaceuticals is based on 3 months time horizon. Increasing Shuttle Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Shuttle Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Shuttle Stock. However, Shuttle Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.87 | Real 0.84 | Hype 0.95 | Naive 0.71 |
The intrinsic value of Shuttle Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Shuttle Pharmaceuticals' stock price.
Estimating the potential upside or downside of Shuttle Pharmaceuticals helps investors to forecast how Shuttle stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Shuttle Pharmaceuticals more accurately as focusing exclusively on Shuttle Pharmaceuticals' fundamentals will not take into account other important factors: When choosing an evaluation method for Shuttle Pharmaceuticals, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Shuttle Pharmaceuticals Cash |
|
Shuttle Valuation Trend
Shuttle Pharmaceuticals' real value analysis enables investors to forecast the earnings more efficiently. Using both Shuttle Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Shuttle Pharmaceuticals Total Value Analysis
Shuttle Pharmaceuticals is at this time projected to have valuation of 3.6 M with market capitalization of 3.19 M, debt of 1.09 M, and cash on hands of 50.44 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Shuttle Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.6 M | 3.19 M | 1.09 M | 50.44 K |
Shuttle Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Shuttle is to check how much profit was generated for every dollar of assets it reports. Shuttle Pharmaceuticals has a negative utilization of assets of -0.62 %, losing $0.006169 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Shuttle Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Shuttle Pharmaceuticals Ownership Allocation
Shuttle Pharmaceuticals maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Shuttle Pharmaceuticals Profitability Analysis
Net Loss for the year was (6.59 M) with profit before overhead, payroll, taxes, and interest of 0.About Shuttle Pharmaceuticals Valuation
An absolute valuation paradigm, as applied to Shuttle Stock, attempts to find the value of Shuttle Pharmaceuticals based on its fundamental and basic technical indicators. By analyzing Shuttle Pharmaceuticals's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Shuttle Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Shuttle Pharmaceuticals. We calculate exposure to Shuttle Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Shuttle Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -6.8 K | -7.2 K |
Shuttle Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.9 M |
Shuttle Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Shuttle Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Shuttle we look at many different elements of the entity such as Shuttle's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Shuttle Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Shuttle Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Shuttle Pharmaceuticals' worth.Complementary Tools for Shuttle Stock analysis
When running Shuttle Pharmaceuticals' price analysis, check to measure Shuttle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shuttle Pharmaceuticals is operating at the current time. Most of Shuttle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Shuttle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shuttle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Shuttle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |